Conclusion CA19-9 self is not an absolute tumor marker.
结论CA19 - 9本身并不完全是肿瘤标志物。
It can be used as a tumor marker in the diagnosis of HCC.
端粒酶有可能成为诊断原发性肝细胞癌的肿瘤标志物。
However, still lack an ideal tumor marker of colorectal cancer.
但是，迄今为止尚无理想的肿瘤标记物。
Some types of tumors can be measured in the blood with a "tumor marker".
有些肿瘤可以通过血液中的肿瘤标志物来检测。
If the chemotherapy is working, one would expect the tumor marker to decrease.
如果接受化疗，则希望肿瘤标志物降低。
Artificial neural network (ANN); Tumor marker; Colorectal carcinoma; Diagnosis.
人工神经网络；肿瘤标志物；结直肠癌；诊断。
RESULTS: tumor reduction and decreased tumor marker were observed in 4 patients.
结果：在4位患者中观察到肿瘤缩小和肿瘤标记物的减少。
Conclusion NSE can be used as a useful tumor marker in patients with lung cancer.
结论：血清nse是一种有效的肺癌肿瘤标志物。
DKK 1 autoantibody may become a useful tumor marker in the diagnosis and treatment of NSCLC.
DKK - 1自身抗体可能成为非小细胞肺癌诊断、治疗中一种有用的肿瘤标志物。
The sensitivity of lung cancer diagnosis is raised by combined assay with serum tumor marker.
血清肿瘤标志物联合检测可提高诊断肺癌敏感性。
Conclusion Urinary sarcosine could be used as a useful tumor marker for the diagnosis of CAP.
结论尿肌氨酸有可能成为可用于诊断CAP的具有一定临床应用价值的肿瘤标记物。
Conclusion Telomerase activity may be used as tumor marker in the diagnosis of malignant tumors.
端粒酶可以作为一种有效的恶性肿瘤标记物用于恶性肿瘤的诊断。
Recently the effect of tumor marker on bone metastasis in breast cancer was regarded increasingly.
近年来，肿瘤标志物在乳腺癌骨转移中的作用日益受到重视。
It is expected that this promising molecular tumor marker would soon be put into routine clinical use.
可以预测，这一极具有应用前景的分子肿瘤标志物不久将会在临床上被广泛应用。
Methods The ultrasound imaging, tumor marker CA125 in 47 cases with early ovarian carcinoma were analyzed.
方法分析经超声、肿瘤标记物ca12 5检查，并经手术及病理证实的早期卵巢癌患者47例。
Objective:To evaluate the clinical significance of serum tumor marker CA15-3 in patients with breast cancer.
目的：评价血清肿瘤标志物CA15 - 3在乳腺癌中的临床应用价值。
Objective: To evaluate the effect of osteopontin as serum tumor marker on the diagnosis of pancreatic cancer.
目的：评价骨桥蛋白作为肿瘤血清标记物在胰腺癌诊断中的作用。
Objective To investigate the possibility of using telomerase as a tumor marker for human primary lung cancer.
目的探讨端粒酶作为原发性肺癌肿瘤标记物的可能性。
Cholangiocarcinoma related antigen (CCRA) is a new tumor marker isolated from human cholangiocarcinoma tissue.
胆管癌相关抗原(CCRA)是我们从人胆管癌组织中提取的一种新的肿瘤标志物。
Objective:To establish a new method to detect the tumor marker in patients with nasopharyngeal carcinoma (NPC).
前言： 目的：建立一种鼻咽恶性肿瘤标志物的测定方法。
Objective To discuss application of multi-tumor marker protein chip detection system (C-12) in tumor screening.
目的讨论12种肿瘤标志物蛋白芯片检测系统(C - 12)在肿瘤筛查的应用。
Objective: To evaluate the effect of osteopontin (OPN) as serum tumor marker on the diagnosis of pancreatic cancer.
目的：评价骨桥蛋白(OPN)作为肿瘤血清标记物在胰腺癌诊断中的作用。
Objective To discuss the diagnostic value of multiple tumor marker protein biochip detective system for lung cancer.
目的探讨多种肿瘤标志物蛋白芯片检测系统对肺癌的诊断价值。
Objective To evaluate the diagnostic values of multiple tumor marker protein biochip detective system for lung cancer.
目的研究多种肿瘤标志物蛋白芯片检测系统对肺癌的诊断价值。
The article reviewed the development of tumor marker research on diagnosis, treatment of bone metastasis in breast cancer.
对部分肿瘤标志物在乳腺癌骨转移诊断、治疗以及疗效监测等方面研究进展进行了综述。
Objective To evaluate the diagnostic values of multi tumor marker protein biochip detective system for primary hepatic cancer.
目的研究多种肿瘤标记物蛋白芯片检测系统对原发性肝癌的诊断价值。
Conclusion GPC3 protein is distributed widely in the tissues of liver cancer, which may be a novel tumor marker for liver cancer.
结论GPC 3蛋白广泛存在于肝癌组织中，很可能成为一种新的肝癌肿瘤标志物。
Objective To investigate the diagnostic value of multi-tumor marker protein biochip detective system in the diagnosis of ovarian cancer.
目的研究多种肿瘤标志物蛋白芯片检测系统对卵巢癌的诊断价值。
Objective: To investigate the clinical value of CA242 and CA19-9 (tumor marker) in the diagnosis, treatment and prognosis of colorectal cancer.
目的：评价肿瘤标志物CA242与CA19 - 9在大肠癌诊断、治疗和预后中的临床意义。
Objective: To investigate the clinical value of CA242 and CA19-9 (tumor marker) in the diagnosis, treatment and prognosis of colorectal cancer.
目的：评价肿瘤标志物CA242与CA19 - 9在大肠癌诊断、治疗和预后中的临床意义。
应用推荐